| ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making HJ Schmoll, E Van Cutsem, A Stein, V Valentini, B Glimelius, ... Annals of oncology 23 (10), 2479-2516, 2012 | 1858 | 2012 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 401 | 2022 |
| A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa E Wilkinson, M Giovanetti, H Tegally, JE San, R Lessells, D Cuadros, ... Science 374 (6566), 423-431, 2021 | 189 | 2021 |
| Treatment of diffuse pigmented villonodular synovitis of the knee with combined surgical and radiosynovectomy WAM Nassar, AA Bassiony, HA Elghazaly HSS Journal® 5 (1), 19-23, 2009 | 100 | 2009 |
| The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ... Science 378 (6615), eabq5358, 2022 | 91 | 2022 |
| Clinic-pathological pattern of hepatocellular carcinoma (HCC) in Egypt H Elghazaly, A Gaballah, NB Eldin Annals of Oncology 29, v5-v6, 2018 | 34 | 2018 |
| Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS … SHA Agwa, MM Kamel, H Elghazaly, AM Abd Elsamee, H Hafez, ... Genes 12 (6), 830, 2021 | 32 | 2021 |
| All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer H Tawfik, Y Rostom, H Elghazaly Cancer chemotherapy and pharmacology 71, 913-919, 2013 | 31 | 2013 |
| Implementation of breast cancer continuum of care in low-and middle-income countries during the COVID-19 pandemic H Elghazawy, J Bakkach, MS Zaghloul, A Abusanad, MM Hussein, ... Future Oncology 16 (31), 2551-2567, 2020 | 24 | 2020 |
| Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers MF Tolba, H Elghazaly, E Bousoik, MMA Elmazar, SM Tolaney Clinical and Translational Oncology 23, 1979-1994, 2021 | 19 | 2021 |
| NCCN clinical practice guidelines in oncology (NCCN guidelines) JA Ajani, TA D’Amico, K Almhanna, D Bentrem, S Besh, ... Gastric cancer, version 3, 2018 | 19* | 2018 |
| Positive lymph‐node breast cancer patients–activation of NF‐κB in tumor‐associated leukocytes stimulates cytokine secretion that promotes metastasis via C‐C chemokine receptor … EA El‐Ghonaimy, M El‐Shinawi, SA Ibrahim, H El‐Ghazaly, ... The FEBS Journal 282 (2), 271-282, 2015 | 18 | 2015 |
| Characterization of tumor mutation burden (TMB) in gastrointestinal (GI) cancers. ME Salem, J Xiu, BA Weinberg, WS El-Deiry, LM Weiner, Z Gatalica, Z Liu, ... Journal of Clinical Oncology 35 (4_suppl), 530-530, 2017 | 16 | 2017 |
| Molecular variances between rectal and left-sided colon cancers. J Marshall, HJ Lenz, J Xiu, WS El-Deiry, J Swensen, H El Ghazaly, ... Journal of Clinical Oncology 35 (4_suppl), 522-522, 2017 | 15 | 2017 |
| Can unenhanced multiparametric MRI substitute gadolinium-enhanced MRI in the characterization of vertebral marrow infiltrative lesions? DZ Zidan, HA Elghazaly The Egyptian Journal of Radiology and Nuclear Medicine 45 (2), 443-453, 2014 | 15 | 2014 |
| The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low‐and middle‐income countries and the MENA region H Elghazaly, AT Aref, BO Anderson, B Arun, CH Yip, H Abdelaziz, ... International journal of cancer 149 (3), 505-513, 2021 | 13 | 2021 |
| In silico identification and clinical validation of a novel long non-coding RNA/mRNA/miRNA molecular network for potential biomarkers for discriminating SARS CoV-2 infection … SHA Agwa, H Elghazaly, MSE Meteini, SM Shawky, M Ali, ... Cells 10 (11), 3098, 2021 | 12 | 2021 |
| MicroRNA‐21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2‐positive metastatic breast cancer M Badr, H Said, ML Louka, HA Elghazaly, A Gaballah, ... Journal of Cellular Biochemistry 120 (3), 3459-3466, 2019 | 12 | 2019 |
| ABHD4-regulating RNA panel: novel biomarkers in acute coronary syndrome diagnosis SHA Agwa, SS Elzahwy, MS El Meteini, H Elghazaly, M Saad, ... Cells 10 (6), 1512, 2021 | 11 | 2021 |
| Breast-gynaecological & immuno-oncology international cancer conference (BGICC) consensus and recommendations for the management of triple-negative breast cancer H Elghazaly, HS Rugo, HA Azim, SM Swain, B Arun, M Aapro, EA Perez, ... Cancers 13 (9), 2262, 2021 | 11 | 2021 |
Ahmed GaballahProfessor of Clinical oncology, faculty of medicine, Ain Shams universityVerified email at med.asu.edu.eg
